These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23521680)

  • 1. Chymase inhibition attenuates monocrotaline-induced sinusoidal obstruction syndrome in hamsters.
    Masubuchi S; Komeda K; Takai S; Jin D; Tashiro K; Li ZL; Otsuki Y; Okamura H; Hayashi M; Uchiyama K
    Curr Med Chem; 2013; 20(21):2723-9. PubMed ID: 23521680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chymase inhibition attenuates lipopolysaccharide/ d-galactosamine-induced acute liver failure in hamsters.
    Imai Y; Takai S; Jin D; Komeda K; Tashiro K; Li ZL; Otsuki Y; Okamura H; Hayashi M; Uchiyama K
    Pharmacology; 2014; 93(1-2):47-56. PubMed ID: 24457951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chymase inhibition improves vascular dysfunction and survival in stroke-prone spontaneously hypertensive rats.
    Takai S; Jin D; Chen H; Li W; Yamamoto H; Yamanishi K; Miyazaki M; Higashino H; Yamanishi H; Okamura H
    J Hypertens; 2014 Aug; 32(8):1637-48; discussion 1649. PubMed ID: 24886822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of chymase-dependent matrix metalloproteinase-9 activation on indomethacin-induced small intestinal damages in rats.
    Kakimoto K; Takai S; Murano M; Ishida K; Yoda Y; Inoue T; Jin D; Umegaki E; Higuchi K
    J Pharmacol Exp Ther; 2010 Feb; 332(2):684-9. PubMed ID: 19996300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chymase as a Novel Therapeutic Target in Acute Pancreatitis.
    Kuramoto T; Jin D; Komeda K; Taniguchi K; Hirokawa F; Takai S; Uchiyama K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes.
    Takai S; Jin D; Ohzu M; Tanaka K; Miyazaki M
    J Pharmacol Sci; 2009 Aug; 110(4):459-65. PubMed ID: 19652453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic sesamol attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats by inhibiting matrix metalloproteinase-9.
    Periasamy S; Hsu DZ; Chen SY; Yang SS; Chandrasekaran VR; Liu MY
    Cell Biochem Biophys; 2011 Nov; 61(2):327-36. PubMed ID: 21681587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet.
    Miyaoka Y; Jin D; Tashiro K; Komeda K; Masubuchi S; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    J Pharmacol Sci; 2017 Jul; 134(3):139-146. PubMed ID: 28673635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
    Palaniyandi SS; Nagai Y; Watanabe K; Ma M; Veeraveedu PT; Prakash P; Kamal FA; Abe Y; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1213-21. PubMed ID: 17895529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease.
    Liu WX; Wang Y; Sang LX; Zhang S; Wang T; Zhou F; Gu SZ
    World J Gastroenterol; 2016 Feb; 22(5):1826-33. PubMed ID: 26855541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chymase inhibition attenuates tetrachloride-induced liver fibrosis in hamsters.
    Komeda K; Takai S; Jin D; Tashiro K; Hayashi M; Tanigawa N; Miyazaki M
    Hepatol Res; 2010 Aug; 40(8):832-40. PubMed ID: 20626468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice.
    Terai K; Jin D; Watase K; Imagawa A; Takai S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
    Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
    J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
    Miyata T; Tajima H; Hirata M; Nakanuma SI; Makino I; Hayashi H; Oyama K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Iseki S; Harada SI; Wakayama T; Ohta T
    J Gastroenterol Hepatol; 2018 Apr; 33(4):950-957. PubMed ID: 28960464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice.
    Takato H; Yasui M; Ichikawa Y; Waseda Y; Inuzuka K; Nishizawa Y; Tagami A; Fujimura M; Nakao S
    Exp Lung Res; 2011 Mar; 37(2):101-8. PubMed ID: 21128860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic sesame oil attenuates sinusoidal obstruction syndrome by inhibiting matrix metalloproteinase-9 and oxidative stress.
    Periasamy S; Yang SS; Chen SY; Chang CC; Liu MY
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):529-37. PubMed ID: 22821006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats.
    Zhang J; Sheng Y; Shi L; Zheng Z; Chen M; Lu B; Ji L
    Eur J Pharmacol; 2017 Jan; 795():160-168. PubMed ID: 27979702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic oral sesame oil is ineffectual against monocrotaline-induced sinusoidal obstruction syndrome in rats.
    Periasamy S; Chien SP; Liu MY
    JPEN J Parenter Enteral Nutr; 2013 Jan; 37(1):129-33. PubMed ID: 22544841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin attenuates monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats via activation of Sirtuin-3.
    Ren X; Xu K; Xu J; Mei Q
    J Biochem Mol Toxicol; 2023 Sep; 37(9):e23422. PubMed ID: 37350538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
    Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
    J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.